Catalyst Wire Dossier Catalyst Wire Dossier

Brimonidine Tartrate Ophthalmic Solution 0.15%

brimonidine tartrate
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Brimonidine Tartrate Ophthalmic Solution 0.15%, covering 2006-12-20 to 2023-03-29. Get the full timeline:

Most recent: FDA Approved: BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% — Original Application (Alembic Pharmaceuticals Limited)

See pricing